Technology
Research
Personalized Treatment
Glucose Monitoring & Insulin Delivery
Therapeutic Discovery and Development
AACE 2026: AI moves from hype to reality in diabetes care
AACE Endocrine AI is published by Conexiant under a license arrangement with the American Association of Clinical Endocrinology, Inc. (AACE®). The ideas and opinions expressed in AACE Endocrine AI do not necessarily reflect those of Conexiant or AACE. For more information, see Policies.